Tarsus Pharmaceuticals, Inc. SEC filings TARS

Tarsus Pharmaceuticals, Inc. has 676 filings in SEC EDGAR's recent list, going back to Aug 7, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

Tarsus Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Nov 5, 2026 Nov 3, 2026
3 Initial insider ownership Nov 5, 2026 Nov 1, 2026
SCHEDULE 13G Ownership over 5% (passive) Nov 5, 2026 —
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 3, 2026 Nov 3, 2026
S-3ASR Automatic shelf registration Oct 13, 2026 —
S-3ASR Automatic shelf registration Oct 13, 2026 —
8-K/A Amended current report Oct 13, 2026 Sep 4, 2026
4 Insider transaction Sep 17, 2026 Sep 15, 2026
4 Insider transaction Sep 17, 2026 Sep 15, 2026
4 Insider transaction Sep 17, 2026 Sep 15, 2026
144 Notice of proposed sale Sep 15, 2026 —
8-K Current report
Acquisition or sale of assets, Other events
Sep 10, 2026 Sep 4, 2026
4 Insider transaction Sep 9, 2026 Sep 4, 2026
4 Insider transaction Sep 9, 2026 Sep 4, 2026
4 Insider transaction Sep 9, 2026 Sep 4, 2026
144 Notice of proposed sale Sep 4, 2026 —
144 Notice of proposed sale Sep 4, 2026 —
144 Notice of proposed sale Sep 4, 2026 —
144 Notice of proposed sale Sep 4, 2026 —
4 Insider transaction Sep 3, 2026 Sep 2, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
144 Notice of proposed sale Sep 2, 2026 —
144 Notice of proposed sale Sep 2, 2026 —
144 Notice of proposed sale Sep 2, 2026 —
144 Notice of proposed sale Sep 2, 2026 —
144 Notice of proposed sale Sep 1, 2026 —
144 Notice of proposed sale Sep 1, 2026 —
144 Notice of proposed sale Aug 25, 2026 —
144 Notice of proposed sale Aug 19, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 6, 2026 Aug 5, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 6, 2026 Jul 31, 2026
8-K Current report
Officer or director change
Jul 13, 2026 Jul 13, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Jul 8, 2026 Jul 6, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
8-K Current report
Shareholder vote results
Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 22, 2026 Jun 17, 2026
4 Insider transaction Jun 17, 2026 Jun 15, 2026
4 Insider transaction Jun 17, 2026 Jun 15, 2026
4 Insider transaction Jun 17, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 17, 2026 —
144 Notice of proposed sale Jun 16, 2026 —
4 Insider transaction Jun 16, 2026 Jun 12, 2026
4 Insider transaction Jun 16, 2026 Jun 12, 2026
4 Insider transaction Jun 16, 2026 Jun 12, 2026
4 Insider transaction Jun 16, 2026 Jun 12, 2026
4 Insider transaction Jun 16, 2026 Jun 12, 2026
4 Insider transaction Jun 16, 2026 Jun 12, 2026
144 Notice of proposed sale Jun 15, 2026 —
144 Notice of proposed sale Jun 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 8, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 6, 2026 —
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 25, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 24, 2026 Mar 20, 2026
144 Notice of proposed sale Mar 20, 2026 —
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
144 Notice of proposed sale Mar 19, 2026 —
144 Notice of proposed sale Mar 19, 2026 —
144 Notice of proposed sale Mar 19, 2026 —
144 Notice of proposed sale Mar 19, 2026 —
144 Notice of proposed sale Mar 19, 2026 —
144 Notice of proposed sale Mar 19, 2026 —
144 Notice of proposed sale Mar 19, 2026 —
144 Notice of proposed sale Mar 18, 2026 —
144 Notice of proposed sale Mar 18, 2026 —
144 Notice of proposed sale Mar 18, 2026 —
144 Notice of proposed sale Mar 18, 2026 —
144 Notice of proposed sale Mar 18, 2026 —
144 Notice of proposed sale Mar 18, 2026 —
144 Notice of proposed sale Mar 18, 2026 —
4 Insider transaction Mar 18, 2026 Mar 16, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
144 Notice of proposed sale Mar 17, 2026 —
144 Notice of proposed sale Mar 17, 2026 —
144 Notice of proposed sale Mar 17, 2026 —
144 Notice of proposed sale Mar 17, 2026 —
144 Notice of proposed sale Mar 17, 2026 —
144 Notice of proposed sale Mar 17, 2026 —
144 Notice of proposed sale Mar 17, 2026 —
144 Notice of proposed sale Mar 16, 2026 —
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 5, 2026 Mar 4, 2026
144 Notice of proposed sale Mar 4, 2026 —
S-8 Employee stock plan registration Feb 23, 2026 —
10-K Annual report Feb 23, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 23, 2026 Feb 23, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
3 Initial insider ownership Feb 20, 2026 Feb 18, 2026
8-K Current report
Officer or director change
Feb 18, 2026 Feb 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Jan 14, 2026 Dec 15, 2025
8-K Current report
Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
144 Notice of proposed sale Jan 2, 2026 —
4 Insider transaction Dec 30, 2025 Dec 24, 2025
144 Notice of proposed sale Dec 29, 2025 —
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 17, 2025 Dec 15, 2025
4 Insider transaction Dec 17, 2025 Dec 15, 2025
144 Notice of proposed sale Dec 16, 2025 —
144 Notice of proposed sale Dec 16, 2025 —
144 Notice of proposed sale Dec 15, 2025 —
144 Notice of proposed sale Dec 15, 2025 —
4 Insider transaction Dec 8, 2025 Dec 4, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
4 Insider transaction Sep 26, 2025 Sep 24, 2025
144 Notice of proposed sale Sep 24, 2025 —
4 Insider transaction Sep 18, 2025 Sep 16, 2025
4 Insider transaction Sep 16, 2025 Sep 15, 2025
4 Insider transaction Sep 10, 2025 Sep 8, 2025
144 Notice of proposed sale Sep 8, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Aug 13, 2025 Aug 11, 2025
144 Notice of proposed sale Aug 11, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 28, 2025 —
4 Insider transaction Jun 18, 2025 Jun 16, 2025
8-K Current report
Shareholder vote results
Jun 18, 2025 Jun 12, 2025
144 Notice of proposed sale Jun 17, 2025 —
4 Insider transaction Jun 17, 2025 Jun 13, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
144 Notice of proposed sale Jun 16, 2025 —
4 Insider transaction Jun 11, 2025 Jun 9, 2025
144 Notice of proposed sale Jun 9, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 7, 2025 —
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 1, 2025 May 1, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Jun 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 24, 2025 —
4 Insider transaction Mar 26, 2025 Mar 24, 2025
144 Notice of proposed sale Mar 24, 2025 —
4 Insider transaction Mar 20, 2025 Mar 18, 2025
4 Insider transaction Mar 20, 2025 Mar 18, 2025
4 Insider transaction Mar 20, 2025 Mar 18, 2025
4 Insider transaction Mar 20, 2025 Mar 18, 2025
4 Insider transaction Mar 20, 2025 Mar 18, 2025
4 Insider transaction Mar 20, 2025 Mar 18, 2025
144 Notice of proposed sale Mar 20, 2025 —
144 Notice of proposed sale Mar 20, 2025 —
144 Notice of proposed sale Mar 20, 2025 —
144 Notice of proposed sale Mar 20, 2025 —
144 Notice of proposed sale Mar 20, 2025 —
144 Notice of proposed sale Mar 20, 2025 —
144 Notice of proposed sale Mar 19, 2025 —
144 Notice of proposed sale Mar 19, 2025 —
144 Notice of proposed sale Mar 19, 2025 —
144 Notice of proposed sale Mar 19, 2025 —
144 Notice of proposed sale Mar 19, 2025 —
144 Notice of proposed sale Mar 19, 2025 —
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
TARS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Irvine, CA
SEC filer status
Large accelerated filer
SEC CIK
1819790

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.